05
Jul
Jul
Peptide analogs interacting with incretin pathways continue to attract significant attention within metabolic and endocrine research communities. Among the most frequently discussed are semaglutide, primarily associated with GLP-1 receptor activity, and tirzepatide, which engages both GLP-1 and GIP receptor systems. Mechanisms Under Investigation Published work commonly evaluates: Why Researchers Compare Them Dual-agonist behavior introduces additional […]